Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.79 Million - $3.39 Million
17,000 Added 4.89%
364,300 $71.9 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $603,681 - $704,964
-3,900 Reduced 1.11%
347,300 $59.6 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $2.81 Million - $3.2 Million
-17,600 Reduced 4.77%
351,200 $64 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $24.6 Million - $27.7 Million
-178,800 Reduced 32.65%
368,800 $57.2 Million
Q3 2023

May 14, 2024

BUY
$133.59 - $154.65 $23.9 Million - $27.7 Million
178,800 Added 48.48%
547,600 $81.6 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $7.95 Million - $9.2 Million
59,500 Added 12.19%
547,600 $81.6 Million
Q2 2023

May 14, 2024

BUY
$132.51 - $164.9 $30.6 Million - $38.1 Million
231,100 Added 89.92%
488,100 $65.8 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $30.6 Million - $38.1 Million
231,100 Added 89.92%
488,100 $65.8 Million
Q1 2023

May 14, 2024

SELL
$144.61 - $166.54 $4.71 Million - $5.43 Million
-32,600 Reduced 11.26%
257,000 $41 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $4.71 Million - $5.43 Million
-32,600 Reduced 11.26%
257,000 $41 Million
Q4 2022

May 14, 2024

BUY
$138.31 - $165.87 $11.5 Million - $13.8 Million
83,000 Added 40.17%
289,600 $46.8 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $11.5 Million - $13.8 Million
83,000 Added 40.17%
289,600 $46.8 Million
Q3 2022

May 14, 2024

SELL
$134.21 - $153.93 $7.33 Million - $8.4 Million
-54,600 Reduced 20.9%
206,600 $27.7 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $7.33 Million - $8.4 Million
-54,600 Reduced 20.9%
206,600 $27.7 Million
Q2 2022

May 14, 2024

SELL
$137.62 - $174.96 $14.8 Million - $18.8 Million
-107,600 Reduced 29.18%
261,200 $40 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $4.36 Million - $5.55 Million
31,700 Added 13.81%
261,200 $40 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $45.7 Million - $56.7 Million
-346,300 Reduced 60.14%
229,500 $37.2 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $5.75 Million - $7.27 Million
53,500 Added 10.24%
575,800 $78 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $55.6 Million - $63.1 Million
522,300 New
522,300 $56.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.